Skip to main content
    C

    Corvus Pharmaceuticals Inc (CRVS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.17
    -0.43 (-4.06%)

    Market Cap: $897.52M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Corvus Pharmaceuticals Inc (CRVS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Corvus Pharmaceuticals (CRVS) has a latest price of $10.17 on Nov 17, 2026, 62.3% below its 52-week high of $26.95. Its price rose 16.0% over the past 12 months. The month-end price fell 24.9% over the 10 years through Oct 2026, a compound annual decline of 2.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $20.77 in Mar 2017 and its lowest $0.73 in Feb 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CRVS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CRVS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 34.0%, and over 6 months it fell 11.6%. The month-end price rose 787.6% over the 3 years through Oct 2026, a compound annual rate of 107.0%.

    PeriodChange
    1 month+5.4%
    3 months-34.0%
    6 months-11.6%
    12 months+16.0%
    12 months, with dividends+16.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+787.6%+107.0%
    5 years+121.4%+17.2%
    10 years-24.9%-2.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 204.0%, and its weakest was 2022, when it fell 64.7%.

    YearCloseChange
    2026 through Oct 2026$10.03+30.3%
    2025$7.70+43.9%
    2024$5.35+204.0%
    2023$1.76+107.1%
    2022$0.85-64.7%
    2021$2.41-32.3%
    2020$3.56-34.6%
    2019$5.44+48.2%
    2018$3.67-64.6%
    2017$10.36-27.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 7.8% below its 50-day average of $11.03 and 26.8% below its 200-day average of $13.89.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$10.17
    52-week high$26.95-62.3%
    52-week low$6.39+59.2%
    50-day average$11.03-7.8%
    200-day average$13.89-26.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 70.5%.

    MeasureValue
    1-year beta0.67
    Largest fall, 1 year-63.2%
    Largest fall, 3 years-70.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CRVS

    What is CRVS's 1-year price change?

    Corvus Pharmaceuticals's price rose 16.0% over the past 12 months. With dividends included, the 12-month total return was 16.0%.

    What is CRVS's 5-year price change?

    Corvus Pharmaceuticals's month-end price rose 121.4% over the 5 years through Oct 2026, a compound annual rate of 17.2%. These figures leave out dividends.

    What is CRVS's 52-week high and low?

    Corvus Pharmaceuticals's 52-week high is $26.95 and its 52-week low is $6.39. Its latest price of $10.17 on Nov 17, 2026 is 62.3% below the high.

    What is CRVS's beta?

    Corvus Pharmaceuticals's 1-year beta against the S&P 500 is 0.67, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 63.2%.

    Is the CRVS chart free?

    Yes. Advanced Charting for CRVS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.